In the News

The biotechnology industry uses advances in genetics research to develop products for human diseases and conditions. This section includes news on pharmaceutical companies, mergers and acquisitions, drug development, export and import of drugs, legislation, advertising and influence.

Could blocking these proteins stop breast cancer?
A study suggests that blocking certain epigenetic proteins with drugs could prevent women at high risk of breast cancer from developing the disease.

Type 2 diabetes: New pill could 'mimic the effects of surgery'
A material that temporarily coats the small intestine and can be taken in pill form before a meal reduced glucose response by 47 percent in rats.

This 'light-activated' drug could treat Parkinson's
A drug activated in the brain using light delivered by implanted optical fiber improved motor function and reduced Parkinson's symptoms in mice.

Atherosclerosis: Could there be a best time of day for medication?
New research finds that the biological processes of atherosclerosis vary according to time of day and may have implications for timing of medication.

One shot may block chemo pain for several weeks
One injection of a protein into the spines of mice reversed pain states induced by chemotherapy for 2 months by altering pain processes in cells.

Could Viagra and a flu shot kill cancer?
A Viagra, Cialis, and inactivated flu vaccine combination reduced cancer spread in a mouse model of post-surgery metastasis by helping the immune system.

This 'metastasis-blocking' compound may stop the spread of cancer
A compound that targets a unique structure in cancer cell nuclei and has links to metastasis potential stopped cancer spread and extended survival in mice.

Cancer: New drug may fight treatment resistance
A new drug that blocks a molecule that cancer cells rely on for transcribing genetic information shows promise in tackling treatment-resistant tumors.

'Natural insecticide' kills advanced prostate cancer cells
Scientists identify a class of drugs that selectively targets and kills advanced prostate cancer cells that lack the tumor-suppressor protein PTEN.

Prostate cancer: How a full stomach could improve treatment
A new study finds that the prostate cancer drug Zytiga is more effective, as well as cheaper, when taken with food, as opposed to on an empty stomach.

Alzheimer's: This antibody may halt brain injury
A study shows how an antibody that targets the APOE protein halved brain levels of plaque in mice with Alzheimer's disease without harming APOE in the blood.

Many non-antibiotic drugs can alter gut bacteria
A new study reveals that many marketed non-antibiotic drugs affect the growth of bacteria in the human gut and may contribute to antibiotic resistance.

Targeting these brain cells may aid weight loss
Scientists may have found a new obesity treatment, after exploring mice's 'feed or flee' responses and finding that they could target the 'control switch.'

How an existing diabetes drug controls pancreatic cancer
A new study suggests that targeting the RET signaling pathway with metformin might offer a new way to stop the growth and spread of pancreatic cancer.

New drug could reduce hot flashes 'by 72 percent'
Fresh analysis of trial data finds that a new class of drug rapidly reduces severity and frequency of hot flashes and other symptoms in menopausal women.

Autism: Anti-cancer drug may improve social behavior
Romidepsin, a compound that is already approved for treating cancer, reversed social deficits in a mouse model of autism by restoring gene expression.

Read More

Awards + Recognition

VMS has experienced more than two decades of success by strategically partnering with our clients to continually provide best-in-class service. We have been recognized for our key contributions and impressive growth.

For the third consecutive year, rated a Great Place to Work® by the experts who produce FORTUNE's 100 Best Companies to Work For® list

Named one of the 2017 Best Workplaces for Giving Back by Fortune magazine and a Great Place to Work
Selected by Fortune magazine as one of the "100 Best Medium Workplaces" in America, with rankings based on anonymous surveys from more than 52,000 employees at Great Place to Work®-certified companies
Great Place to Work® and Fortune magazine recognized VMS BioMarketing as one of the 100 Best Workplaces for Women
Selected as a "Most Valuable Patient Initiative" Finalist and a "Most Valuable HCP Initiative" Finalist at the 2017 Eyeforpharma Awards
Named three times as one of Inc. 500's "Fastest Growing Companies in America"
Recognized by a Fortune 500 pharmaceutical client with a "Global Supplier of the Year" award
Recognized by the Edward Lowe Foundation as one of the "Indiana Companies to Watch" in 2008
Recognized by Working Mother magazine in 2008 as a Top 25 outstanding family-friendly company
Received "Family Friendly Workplace" award from the Indiana Youth Institute in 2008
Highlighted as a "Growth 100" company by the Kelley School of Business Johnson Center for Entrepreneurship and Innovation
Selected as one of Ernst and Young's "Entrepreneur of the Year" finalists
Listed in the top five of the Best Places to Work in Indiana three years in a row